Sidebar

U.S. Food and Drug Administration accepts Soluplus® branded excipient in its program to evaluate safety and acceptability of excipients for use in clinical trials, independent from a specific New Drug Application.

Excipients (inactive ingredients) such as the Soluplus® branded excipient play a critical role in enabling the drug development process for poorly soluble active pharmaceutical ingredients

Merck has acquired Massachusetts-based Erbi Biosystems, a developer of the 2 ml micro-bioreactor platform technology, known as the “Breez™”.

Erbi’s differentiated 2 ml micro-bioreactor platform technology, Breez™, enables rapid lab testing for bioprocessing scale up
Allows Merck to offer full range of bioreactors, from 2ml to 2000L
Adds to company’s expertise in monoclonal antibody (mAb) process development

hubergroup India launched a healthcare initiative for rural areas in the Indian state of Gujarat, collaborating with Rotary Vapi Riverside. As part of this engagement, the ink and speciality chemicals producer hubergroup has sponsored two medical vans equipped with doctors, nurses, and basic medical equipment. These vans will be available in 16 remote villages every week for on-site medical check-ups and examinations. Rotary Vapi Riverside has extensive experience working in the local regions and supports this project with its know-how.

To mark this year’s World Mental Health Day, Shyam Bishen - Head of Health and Healthcare at the World Economic Forum - calls for stakeholders from the public and private sectors to come together and realise the vision of this year's World Mental Health Day to "Make mental health & well-being for all a global priority."

Evonik is celebrating the start of construction of the world’s first commercial rhamnolipid production facility with a groundbreaking ceremony today.

First commercial rhamnolipids production site worldwide
Expands Evonik’s biotechnology platform
Portfolio transformation to sustainable solutions

Page 1 of 3

Meet Our Sponsors

Latest Sponsor News

Articles Most Read

Latest News

Statistics

Articles View Hits
301190

Who's Online

We have 23 guests and no members online